The most common cause of fetal tachycardia is maternal fever. Fetal tachycardia often precedes the maternal fever, and fetal tachycardia confounds the interpretation of electronic fetal monitoring (EFM), increasing the rate of cesarean delivery for non-reassuring fetal status (NRFS). Our hypothesis is that treatment of fetal tachycardia with acetaminophen will significantly lower maternal body temperature and significantly lower baseline fetal heart rate (FHR). The importance is that interpretation of EFM will improve, thus allowing for a decrease in cesarean delivery for NRFS.
This trial is a randomized, non-placebo controlled, assessment of whether acetaminophen can lower maternal temperature and baseline fetal heart rate in laboring patients with fetal tachycardia. Term singleton cephalic pregnancies in active phase labor (spontaneous or induced) with fetal tachycardia will be recruited. Patient will be excluded for: * Exclusion criteria (prior to randomization): * Acetaminophen allergy * Clinical chorioamnionitis * Maternal fever * Non-reassuring fetal status (NRFS), which is the designation for fetal heart rate abnormalities requiring cesarean delivery * Previous cesarean delivery * Multifetal gestation * Breech presentation * Known fetal anomaly * Known contraindication to vaginal delivery Primary outcome measures are: 1. Maternal body temperature (oral) 90 minutes after treatment 2. Baseline FHR Secondary outcome measures are: 1. Temperature difference before and after treatment 2. Rate of cesarean delivery 3. Rate of determination of NRFS 4. Rate of subsequent development of maternal fever 5. Rate of diagnosis of clinical chorioamnionitis 6. Rate of neonatal sepsis Power calculation Internal data collection at our institution of 53 patients showed a mean decrease in temperature of patients in labor with fever receiving acetaminophen is 0.3 degrees C measured an average (mean) of 90 minutes after administration of acetaminophen. Mean oral temperature before acetaminophen was 38.32, SD 0.33. Mean oral temperature after acetaminophen was 38.03, SD 0.85. Sample size calculation shows that 27 patients are needed in each group to show significant difference using alpha 5% and beta 50%.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
13
Acetaminophen 975 mg by mouth once only
New York Hospital Medical Center of Queens
Flushing, New York, United States
Maternal Body Temperature 90 Minutes After Randomization
Fever in labor is identified,consenting and randomization occurs, either acetaminophen is given or no medication is given, then 90 minutes later maternal temperature is recorded.
Time frame: 90 minutes
Baseline Fetal Heart Rate (FHR) After Treatment
Time frame: 90 minutes
Temperature Difference Before and After Treatment
Maternal temperature difference before randomization and 90 minutes after randomization in degrees Centigrade
Time frame: 90 minutes
Rate of Cesarean Delivery
Rate of cesarean delivery
Time frame: Labor--up to 24 hours
Rate of Determination of Non-reassuring Fetal Status
Non-reassuring fetal status is when cesarean delivery or operative vaginal delivery (forceps or vacuum) are performed for fetal heart rate abnormalities.
Time frame: Labor--up to 24 hours
Rate of Subsequent Development of Maternal Fever
Rate of subsequent development of maternal fever, i.e., the number of participants who developed fever.
Time frame: Labor--up to 24 hours
Rate of Diagnosis of Clinical Chorioamnionitis
Rate of diagnosis of clinical chorioamnionitis, i.e., the number of participants who developed chorioamnionitis.
Time frame: Labor--up to 24 hours
Rate of Neonatal Sepsis
the number of participants who developed neonatal sepsis
Time frame: 7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.